Human Subjects Research

You have access to the guidance and resources needed to ensure your human subjects research meets the highest ethical standards and complies with regulations.

Researcher in lab

Navigating the IRB process for human subjects research

Conducting human subjects research at the University of Mississippi requires careful consideration of ethical standards and regulatory compliance. As a researcher, it’s essential to navigate the Institutional Review Board (IRB) process to ensure that your study meets federal, state, and institutional guidelines. This page provides the tools and resources you need to successfully submit, review, and manage your IRB protocol, helping you maintain the highest standards of integrity in your research.

Before your research can start

Before beginning your research, all materials must be submitted for IRB review through the online submission portal. Submit your protocol at least 4 weeks prior to your anticipated research start date. Protocols are reviewed in the order they are received, and it can take 4-6 weeks to receive final approval, depending on the completeness of your application and the type of review required.

Make sure to follow the submission guidelines, which include completing the appropriate application form as well as any supporting documentation based on the type of research you are conducting. If your research involves vulnerable populations or sensitive data, additional considerations may apply.

There are training and forms that you will need to complete, too. Check out the Human Research Handbook for details. 

Looking for where to submit your IRB protocol? Click the button below.

Submit IRB Protocol

Submission and review process

The IRB process depends on the type of research you’re conducting. For process details on each type of review, please refer to the appropriate flowchart:
  • Initial Submission

    An initial submission is the first step in securing IRB approval for your research project. This process applies to any study involving human participants.

    Initial Submission
  • Exempt Review

    Exempt Review is available for research that presents no more than minimal risk to participants and that meets the criteria of select categories outlined in federal regulations.

    Exempt Review
  • Expedited Review

    An expedited review is available for research that poses minimal risk to participants and fits specific regulatory categories, such as surveys, interviews, or studies involving non-invasive procedures.

    Expedited Review
  • Full Board Review

    A full board review is required for research that involves greater than minimal risk to participants or includes sensitive populations.

    Full Board Review

Determining the appropriate review type

Before submitting your human subjects research for review, it's important to determine the appropriate review pathway based on the nature of your study. Research involving human subjects is classified into one of three categories—exempt, expedited, or full board review—each with its own criteria and level of scrutiny. This section will help you identify which type of review your study requires, ensuring that your research is reviewed efficiently and according to federal and institutional guidelines.

If your research involves no more than minimal risk

Research is reviewed for Exempt status by an IRB board member if it involves very minimal or no risk. There are several types of research that may qualify for Exempt status. In general, research which does not propose to disrupt or manipulate the normal life experiences of subjects, incorporate any form of intrusive procedures, or involve deception will be exempt from Full Board review. Projects that involve more than very minimal risk do not qualify for Exempt status.

Please note that all of the rights and protection afforded to human subjects in research are required in Exempt status cases. Researchers engaged in human subjects research that qualifies for Exempt status will need to complete an abbreviated application form and prepare an information sheet, not a full consent form. Researchers must engage in practices that minimize risk, maximize benefit and ensure privacy.

Any research involving protected classes or vulnerable populations of subjects (such as prisoners or mentally disabled persons) or research requiring the use of PHI (protected health information) is rarely Exempt.

If your research involves minimal risk and fits specific categories

Expedited review is a procedure through which certain kinds of research may be reviewed and approved without convening a meeting of the entire IRB. The term "expedited" can be misleading: reviews of this type are not quicker or conducted with less rigor, but fewer reviewers are required for approval.

In general, research may be considered for Expedited review if it involves no more than minimal risk*, does not include intentional deception, does not employ sensitive populations or topics, and includes appropriate consent procedures.

The expedited review procedure may not be used where identification of the subjects and/or their responses would reasonably place them at risk of criminal or civil liability or be damaging to the subjects financial standing, employability, insurability, reputation, or be stigmatizing, unless reasonable and appropriate protections will be implemented so that risks related to invasion of privacy and breach of confidentiality are no greater than minimal risk*.

To qualify for review via expedited procedures, the research must not be greater than minimal risk* and fall into at least one of the expedited categories defined by the federal regulations.

Summary of Expedited Categories:

  1. Clinical studies of drugs and medical devices only when certain conditions are met
  2. Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture in certain populations and within certain amounts
  3. Prospective collection of biological specimens for research purposes by noninvasive means
  4. Collection of data through noninvasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwaves.
  5. Research involving materials (data, documents, records, or specimens) that have been collected, or will be collected solely for non-research purposes
  6. Collection of data from voice, video, digital, or image recordings made for research purposes
  7. Research on individual or group characteristics or behavior or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies

Researchers engaged in human subjects research that qualifies for Expedited review will need to complete a full application form and prepare a consent form, using our template.

If your research involves more than minimal risk or protected populations

All research not qualifying for Exempt status or Expedited review and research involving protected classes of subjects requires Full review. In general research requiring Full review places the subject at greater than minimal risk. Full review means that the research protocol is read, discussed and voted upon by the full IRB board.

Special considerations apply to protecting the welfare of particularly vulnerable populations such as fetuses, children, prisoners, mentally disabled or cognitively impaired persons, terminally ill patients, the elderly, students and employees, survey research that involves AIDS information either with the general public or with vulnerable populations, or economically or educationally disadvantaged persons. Research involving a protected class is required to undergo Full review.

How to submit your IRB application

The review process will not begin until all required materials, including the advisor/chair assurance, have been submitted. Researchers using survey panels should plan for additional time—up to two weeks—to receive the panel and be ready to launch the survey.

When submitting your materials, please name your files as follows:

  • lastname_application
  • lastname_amendment
  • lastname_recruitment
  • (And so on, depending on the type of document you are submitting.)

Even if you are a student, your research is subject to the same review process.

Which form should I use?

Consider the following to determine the correct application form for your research:

  • Does your research involve surveys, interviews, educational/psychological testing, observation of public behavior, educational practices (including children), existing data, or public service evaluations?
  • Are you performing benign behavioral interventions?

If so, use the Exempt Screening/Abbreviated IRB Application form. Complete the checklist to determine if your study qualifies for exempt status. Note: The IRB will make the final eligibility determination.

If your research does not meet these criteria, complete the Full Application to Conduct Research with Human Subjects.

If treatment is included in your research, complete the IRB Consent Form for Treatment Studies.

If treatment is not included, complete the IRB Non-Treatment Studies Consent Form.

Download the IRB Parental Consent Form for child participation in a study.

Best practices for IRB applications

To help reduce the turnaround time for your IRB application, follow these essential tips:

Write your study description as if presenting to a general audience, such as a freshman class. Avoid field-specific jargon to ensure all IRB members can understand your research easily, which helps prevent follow-up questions that could delay the review process.

If your study has multiple phases or interventions, include a clear, simple outline of each step. This makes it easier for reviewers to follow your study’s flow and ensures they can assess the research efficiently.

Ensure your project description is in present tense to avoid confusion about whether certain parts of the study have already been conducted. Use past tense only when describing previous pilot research.

Write your IRB application from scratch instead of editing down larger documents like grants or dissertations. Keep descriptions concise and focused on what is relevant to the IRB, typically in two to four double-spaced pages.

The IRB uses a cost-benefit approach when reviewing applications. Provide a clear explanation of how your research will benefit subjects or science in general to justify any risks involved.

Be transparent about all potential risks in your study description, even if they aren’t included in the consent form. Address how you will manage these risks and reference prior research when possible to contextualize their significance.

Include information on the validity and reliability of your study’s measurement tools. This helps the IRB assess the value of your research and ensures that the risk-to-benefit ratio is acceptable.

Review previously approved applications for studies similar to yours. If you're a student, seek feedback from your advisor. New faculty members should consult more experienced colleagues for input.

If you’re excluding any groups based on race or gender, provide a clear justification for doing so, in line with NIH requirements.

Include scripts for subject recruitment, task instructions, and debriefing. This helps the IRB understand the information participants receive and assess whether it’s sufficient for informed consent.

Ensure consistency and accuracy throughout your application, especially when listing numbers of subjects, ages, and sessions.

If you have any questions, don’t hesitate to contact the IRB for guidance on starting your application or meeting deadlines.

Always submit your application through the online submission portal for efficient processing.

Contact us with IRB questions

If you have any questions about the IRB process, training requirements, or submission guidelines, feel free to reach out to us. We’re here to help guide you through the process and answer any questions you may have. You can reach us through email at irb@olemiss.edu or by phone at (662) 915-5046, or contact us directly:
Mark Van Boening

Mark Van Boening

  • Professor of Economics
Mandy King

Mandy King

  • Assistant Vice Chancellor of Research Integrity, Security, and Compliance
Jeff Neal

Jeff Neal

  • Program Manager
Miranda Core

Miranda Core

  • Research Compliance Specialist II